138 related articles for article (PubMed ID: 5517707)
21. [Therapeutic efficacy of pyridinolcarbamate (Anginin) in patients with combined cerebral and peripheral arteriosclerosis].
Majkowski J; Lysakowska-Sernicka K; Gajewska A; Bilińska-Nigot B; Ostrowski K; Semenicki K
Neurol Neurochir Pol; 1978; 12(4):387-96. PubMed ID: 714218
[TBL] [Abstract][Full Text] [Related]
22. [Pyridinolcarbamate in the therapy of hemicrania syndromes].
Spina A
Acta Neurol (Napoli); 1972; 27(6):610-7. PubMed ID: 4651488
[No Abstract] [Full Text] [Related]
23. [Late results of the pyridinolcarbamate treatment of thrombotic obliterating arterial diseases of the extremities].
Fisanovich TI; Tolstova LG
Khirurgiia (Mosk); 1979 Sep; (9):76-80. PubMed ID: 502312
[No Abstract] [Full Text] [Related]
24. [Nicotinyl in the treatment of arteriosclerosis obliterans of the lower limbs].
Grodzińska L; Basista M; Byrska-Danek A; Kostka-Trabka E
Pol Tyg Lek; 1984 Jun 12-25; 39(25-26):879-81. PubMed ID: 6387654
[No Abstract] [Full Text] [Related]
25. [Treatment of experimental and human athero- sclerosis by a bradykinin antagonist, pyridinol carbamate. (Preliminary report)].
Shimamoto T; Numano F; Fujita T; Atsumi T
Rev Atheroscler (Paris); 1967; 9(2):294-306. PubMed ID: 6064255
[No Abstract] [Full Text] [Related]
26. [Reactive hyperemia test under plethysmographic control in the early diagnosis of arteriosclerosis obliterans of the lower limbs].
Mc Cook Martínez J; Aldama Figueroa A; Bidart Labourdette J
Angiologia; 1981; 33(3):123-8. PubMed ID: 7258725
[No Abstract] [Full Text] [Related]
27. [Use of pyrimidinol-carbamate in the therapy of peripheral obliterative arteriopathies].
Tardito E; Trezzi M; Papackaralambus D
Minerva Cardioangiol; 1970 Dec; 18(12):692-705. PubMed ID: 5532336
[No Abstract] [Full Text] [Related]
28. Comparison of conservative (Prodectin) treatment and surgical intervention in arteriosclerotic obliterative diseases of the lower extremities.
Hunyi L
Ther Hung; 1978; 26(2):77-80. PubMed ID: 684660
[No Abstract] [Full Text] [Related]
29. [Papaverine and limb vascularization. Clinical pharmacological study in patients with stenotic arteriopathies and in those with healthy arteries].
Royer RJ; Schmidt C; Morrot MJ; Humbert F; Kissel P
Therapie; 1972; 27(6):1119-35. PubMed ID: 4676776
[No Abstract] [Full Text] [Related]
30. [Clinical and hemodynamic aspects induced by eledoisin. Plethysmographic study of variations of flow in some forms of obliterating arterial disease of the legs, during intra-arterial infusion of eledoisin].
Chiampo L; La Greca G; Ferrari S; Novarini A
Minerva Cardioangiol; 1965 Jul; 13(7):375-82. PubMed ID: 5838537
[No Abstract] [Full Text] [Related]
31. [Clinical trial of a long-acting vasodilator agent in chronic peripheral obliterating arteriopathy of a sclerotic nature].
Gemma GB; Ghezzi P; Cavaliere P
Minerva Cardioangiol; 1969 May; 17(5):324-32. PubMed ID: 5785730
[No Abstract] [Full Text] [Related]
32. [Progress surveillance of limb artery occlusions].
Bollinger A; Lüthy E
Schweiz Med Wochenschr; 1966 Aug; 96(34):1094-8. PubMed ID: 5985858
[No Abstract] [Full Text] [Related]
33. [Treatment of arteriosclerosis obliterans with pyridinolcarbamate].
Atsumi T; Isokane N; Yamashita S; Sano T; Odakura T; Kurai A
Nihon Naika Gakkai Zasshi; 1967 Sep; 56(9):983-92. PubMed ID: 5627161
[No Abstract] [Full Text] [Related]
34. [Use of buflomedil in the treatment of obliterative arteriopathies of the lower extremities. Clinical and functional study].
Cospite M; Ferrara F; Milio G; Meli F
Clin Ter; 1984 Apr; 109(2):127-35. PubMed ID: 6234122
[No Abstract] [Full Text] [Related]
35. [Study of pyridinolcarbamate in the treatment of diabetic angiopathies and atheromatous arteritis].
Plauchu M; Bussy L; Rondelet J
Lyon Med; 1972 Feb; 227(3):271-7. PubMed ID: 5037162
[No Abstract] [Full Text] [Related]
36. [Comparative evaluation of the activation of the capillary bed (build-up) and of other methods in the study of patients with peripheral obstructive arteriopathies].
Rodolico G; Romeo G; Di Benedetto A; Azzolina P; Giovinetto A; Russo A
Chir Ital; 1967; 19():Suppl 2:307+. PubMed ID: 5190604
[No Abstract] [Full Text] [Related]
37. Modifications of platelet retention in patients treated with pyridinolcarbamate. A preliminary report.
Girolami A; Peruffo R; Emanueli A
Arzneimittelforschung; 1977; 27(6):1202. PubMed ID: 578441
[TBL] [Abstract][Full Text] [Related]
38. Failure of vasodilator drugs in arteriosclerosis obliterans.
Coffman JD; Mannick JA
Ann Intern Med; 1972 Jan; 76(1):35-9. PubMed ID: 4553743
[No Abstract] [Full Text] [Related]
39. [Personal experience on indirect long-term anticoagulant therapy in ambulatory peripheral chronic arteriosclersis obliterans patients].
Raso AM; Silvestrini P
Angiologia; 1968; 20(6):301-16. PubMed ID: 5747170
[No Abstract] [Full Text] [Related]
40. [Lymphographic observations on peripheral arteriopathies of the lower extremities].
Bresadola F; Vallebona D; Tarabella V; Marsico G
Minerva Chir; 1966 May; 21(9):385-7. PubMed ID: 5914402
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
